VC
Vivo Capital Portfolio holdings
AUM
$977M
1-Year Return
209.68%
This Quarter Return
+6.21%
1 Year Return
+209.68%
3 Year Return
+1,480.07%
5 Year Return
+2,591.98%
10 Year Return
–
AUM
$467M
AUM Growth
-$27.9M
(-5.6%)
Cap. Flow
-$4.25M
Cap. Flow
% of AUM
-0.91%
Top 10 Holdings %
Top 10 Hldgs %
72.26%
Holding
31
New
2
Increased
2
Reduced
6
Closed
1
Top Buys
| 1 |
Apellis Pharmaceuticals
APLS
|
+$31.6M |
| 2 |
ZGNX
Zogenix, Inc.
ZGNX
|
+$4.21M |
| 3 |
Soleno Therapeutics
SLNO
|
+$1.97M |
| 4 |
EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
|
+$58.2K |
Top Sells
| 1 |
Aclaris Therapeutics
ACRS
|
+$29.9M |
| 2 |
AIMT
Aimmune Therapeutics, Inc.
AIMT
|
+$5.04M |
| 3 |
SBBP
Strongbridge Biopharma plc.
SBBP
|
+$3.7M |
| 4 |
RVNC
Revance Therapeutics, Inc.
RVNC
|
+$2.13M |
| 5 |
CRISPR Therapeutics
CRSP
|
+$1.18M |
Sector Composition
| 1 | Healthcare | 91.64% |
| 2 | Materials | 2.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
CRISPR Therapeutics
CRSP
$5.08B
| $2.31M | 0.5% |
98,511
-50,367
| -34% | -$1.18M |
|
|
VIRX
27
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $1.85M | 0.4% |
14,286
| – | – |
|
|
TMBR
28
DELISTED
Timber Pharmaceuticals, Inc.
TMBR
| $1.52M | 0.33% |
920
-20
| -2% | -$33.1K |
|
|
AKTX
29
Akari Therapeutics
AKTX
$25.1M
| $1.5M | 0.32% |
17,293
| – | – |
|
|
SLNOW
30
DELISTED
Soleno Therapeutics, Inc. Series A Warrant
SLNOW
| $27K | 0.01% |
188,772
| – | – |
|
|
RVNC
31
DELISTED
Revance Therapeutics, Inc.
RVNC
| – | – |
-77,373
| Closed | -$2.13M |
|